Triple Drug Combination Is Promising Option To Treat Metastatic HER2+ Breast Cancer

[News]

Combining two chemotherapy drugs with trastuzumab (Herceptin) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.

More... (http://www.medicalnewstoday.com/articles/150364.php)